Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics

P. Dundr, N. Singh, B. Nožičková, K. Němejcová, M. Bártů, I. Stružinská

. 2021 ; 16 (1) : 20. [pub] 20210311

Language English Country Great Britain

Document type Journal Article, Review

Grant support
AZV NV19-03-00007 Ministerstvo Zdravotnictví Ceské Republiky
Conceptual development of research organization 64165, General University Hospital in Prague Ministerstvo Zdravotnictví Ceské Republiky
Progress Q28/LF1 Univerzita Karlova v Praze
UNCE204065 Univerzita Karlova v Praze
SVV260367 Univerzita Karlova v Praze
CZ.02.1.01/0.0/0.0/18_046/0015959 European Regional Development Fund
BBMRI_CZ LM2018125 European Regional Development Fund

BACKGROUND: Making the distinction between primary mucinous and metastatic ovarian tumors is often difficult, especially in tumors with a primary source from the gastrointestinal tract, pancreas and biliary tree. The aim of the following paper is to provide an overview of the problematics, with a focus on the possibilities of the differential diagnosis at the macroscopic, microscopic and immunohistochemical level. MAIN BODY: The three main aspects of mucinous ovarian tumors are described in detail, including the comparison of the available diagnostic algorithms based on the evaluation of mostly macroscopic features, characterization of the spectrum of microscopic features, and a detailed analysis of the immunophenotype comparing 20 antibodies with the assessment of their statistical significance for differential diagnosis purposes. Specific features, including Krukenberg tumor and pseudomyxoma peritonei, are also discussed. CONCLUSION: Despite the growing knowledge of the macroscopic and microscopic features of ovarian mucinous tumors and the availability of a wide range of immunohistochemical antibodies useful in this setting, there still remains a group of tumors which cannot be precisely classified without close clinical-pathological cooperation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004540
003      
CZ-PrNML
005      
20220127145152.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13000-021-01079-2 $2 doi
035    __
$a (PubMed)33706757
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Dundr, Pavel $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic. pavel.dundr@vfn.cz
245    10
$a Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics / $c P. Dundr, N. Singh, B. Nožičková, K. Němejcová, M. Bártů, I. Stružinská
520    9_
$a BACKGROUND: Making the distinction between primary mucinous and metastatic ovarian tumors is often difficult, especially in tumors with a primary source from the gastrointestinal tract, pancreas and biliary tree. The aim of the following paper is to provide an overview of the problematics, with a focus on the possibilities of the differential diagnosis at the macroscopic, microscopic and immunohistochemical level. MAIN BODY: The three main aspects of mucinous ovarian tumors are described in detail, including the comparison of the available diagnostic algorithms based on the evaluation of mostly macroscopic features, characterization of the spectrum of microscopic features, and a detailed analysis of the immunophenotype comparing 20 antibodies with the assessment of their statistical significance for differential diagnosis purposes. Specific features, including Krukenberg tumor and pseudomyxoma peritonei, are also discussed. CONCLUSION: Despite the growing knowledge of the macroscopic and microscopic features of ovarian mucinous tumors and the availability of a wide range of immunohistochemical antibodies useful in this setting, there still remains a group of tumors which cannot be precisely classified without close clinical-pathological cooperation.
650    _2
$a mucinózní adenokarcinom $x patologie $7 D002288
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gastrointestinální trakt $x patologie $7 D041981
650    _2
$a lidé $7 D006801
650    _2
$a nádory vaječníků $x patologie $7 D010051
650    _2
$a pankreas $x patologie $7 D010179
650    _2
$a peritoneální nádory $x patologie $7 D010534
650    _2
$a pseudomyxom peritonea $x diagnóza $x patologie $7 D011553
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Singh, Naveena $u Department of Cellular Pathology, Barts Health NHS Trust, Queen Mary University of London, London, UK $u Blizard Institute of Core Pathology, Queen Mary University of London, London, UK
700    1_
$a Nožičková, Barbora $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
700    1_
$a Němejcová, Kristýna $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
700    1_
$a Bártů, Michaela $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
700    1_
$a Stružinská, Ivana $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
773    0_
$w MED00165474 $t Diagnostic pathology $x 1746-1596 $g Roč. 16, č. 1 (2021), s. 20
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33706757 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145148 $b ABA008
999    __
$a ok $b bmc $g 1751865 $s 1155689
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 16 $c 1 $d 20 $e 20210311 $i 1746-1596 $m Diagnostic pathology $n Diagn Pathol $x MED00165474
GRA    __
$a AZV NV19-03-00007 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a Conceptual development of research organization 64165, General University Hospital in Prague $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a Progress Q28/LF1 $p Univerzita Karlova v Praze
GRA    __
$a UNCE204065 $p Univerzita Karlova v Praze
GRA    __
$a SVV260367 $p Univerzita Karlova v Praze
GRA    __
$a CZ.02.1.01/0.0/0.0/18_046/0015959 $p European Regional Development Fund
GRA    __
$a BBMRI_CZ LM2018125 $p European Regional Development Fund
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...